`Prevnar' for pneumococcal disease - it makes cents

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1242, 2000-01, pp. : 5-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

`Prevnar' for pneumococcal disease - it makes cents

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 266, 2000-01 ,pp. : 3-5

Adis International

Access to resources Recommend Favorite

`Prevnar' preventing disease in the US

Inpharma, Vol. 1, Iss. 1386, 2003-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Budesonide/formoterol makes cents in COPD, asthma

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 514, 2006-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Pneumococcal Conjugate Vaccine (Prevnar; PNCRM7): A Review of its Use in the Prevention of Streptococcus pneumoniae Infection

By Darkes M.J.M. Plosker G.L.

Pediatric Drugs, Vol. 4, Iss. 9, 2002-01 ,pp. : 609-630

Adis International

Access to resources Recommend Favorite

The 7-valent pneumococcal CRM197 conjugate vaccine [Prevnar] is now included in the UK child immunisation programme

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 497, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite